Delivery Order SPE2DB20D9226-SPE2DB23FQ59F
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $17,497.94 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is to provide the pharmaceutical product Ocaliva 5 mg tablet to military health facilities supported by DLA worldwide. This delivery order is issued against DMS Pharmaceutical's existing indefinite delivery contract with DLA, contract SPE2DB-13-D-4600, which has a ceiling value of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,748.97 contract is for the delivery of 4564626938 OCALIVA 5 MG TABLET 30S, with a performance period ending on June 4, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) vehicle under the DLA's SPE2DB program, which allows the agency to...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $8,748.97 contract is for the delivery of Ocaliva 5 mg tablets through March 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract, SPE2DB, with the Defense Logistics Agency valued up to $4,999,999 for the provision of a broad range of pharmaceutical items to military...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $26,639.55 contract is for the supply of the drug Ocaliva 5 mg tablets, with a completion date of September 18, 2023. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA, under the SPE2DB...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,748.97 contract is to provide the pharmaceutical product Ocaliva 5 mg Tablet 30s to support the medical supply needs of the Department of Defense (DoD). DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $26,246.91 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of the pharmaceutical product OCALIVA 5 MG TABLET 30S. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
- This federal contract award was issued by the Defense Logistics Agency (DLA) under its Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,748.97 firm fixed-price delivery order is for the supply of 4564539373 (Ocaliva 5 mg Tablet 30s), a pharmaceutical product, with a period of performance through May 28, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to...
- The U.S. Department of Defense's Medical Supply Chain (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,564,170,278 tablets of the prescription drug Ocaliva 10 mg for a total ceiling value of $8,751.19. The contract has an ultimate completion date of April 24, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB, valued up to $4,999,999 through 2025,...
- This federal contract award, valued at $8,748.97, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The delivery order is for the pharmaceutical product Ocaliva 5 mg Tablet 30s and has a firm fixed-price pricing type. DMS Pharmaceutical Group holds a significant single-award indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This IDC,...
- The Defense Logistics Agency awarded a delivery order valued at $10,320.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Ocaliva 5 mg tablets in quantities of 30. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and carries no set-aside designation. DMS Pharmaceutical Group will perform this work at its Park Ridge facility. This...
- SPE2DB20D9226Indefinite Delivery Contract
- SPE2DB20D9226-SPE2DB23FQ59FDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,689.52, is for the supply of Ocaliva 5 mg tablets. This award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The contract has no set-aside designation. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide array of medications, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to the DoD and Department of Veterans Affairs (VA).
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 6/2/23 |